|
Glenmark Pharmaceuticals Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
70979.51 Cr.
|
P/BV
|
6.46
|
Book Value (Rs.)
|
389.58
|
|
52 Week High/Low (Rs.)
|
2538/1793
|
FV/ML
|
1/1
|
P/E(X)
|
52.12
|
|
Bookclosure
|
31/08/2026
|
EPS (Rs.)
|
48.25
|
Div Yield (%)
|
0.20
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 3931.73 | 3760.28 | 3888.00 | 6003.79 | 3059.33 |
| Other Operating Income | 86.75 | 10.31 | 12.62 | 43.08 | 205.11 |
| Total Income From Operations | 4018.48 | 3770.59 | 3900.62 | 6046.87 | 3264.44 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 601.07 | 731.20 | 775.30 | 722.50 | 732.47 |
| Purchase of Traded Goods | 660.75 | 446.29 | 748.56 | 620.45 | 581.34 |
| Increase/Decrease in Stocks | -16.02 | -5.21 | -228.76 | -78.44 | -298.23 |
| Employees Cost | 934.70 | 887.44 | 841.40 | 1086.26 | 762.75 |
| Depreciation | 173.17 | 147.91 | 154.45 | 141.20 | 129.93 |
| Other Expenses | 1033.19 | 948.27 | 894.37 | 1336.56 | 905.59 |
| Total Expenses | 3386.86 | 3155.90 | 3185.31 | 3828.52 | 2813.85 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 631.62 | 614.69 | 715.30 | 2218.35 | 450.59 |
| Other Income | 65.76 | 189.08 | 44.47 | 200.63 | 26.44 |
| P/L Before Interest, Excpt. Items & Tax | 697.39 | 803.77 | 759.77 | 2418.98 | 477.04 |
| Interest | 54.00 | 42.60 | 41.43 | 66.46 | 58.23 |
| P/L Before Exceptional Items & Tax | 643.39 | 761.17 | 718.34 | 2352.52 | 418.81 |
| Exceptional Items | 0.00 | -373.40 | -184.34 | -1385.12 | -323.23 |
| P/L Before Tax | 643.39 | 387.77 | 534.00 | 967.40 | 95.58 |
| Tax | 160.56 | 86.45 | 130.77 | 356.97 | 48.61 |
| P/L After Tax from Ordinary Activities | 482.83 | 301.32 | 403.23 | 610.43 | 46.97 |
| Net Profit/Loss For the Period | 482.83 | 301.32 | 403.23 | 610.43 | 46.97 |
| Minority Interest | 0.10 | 0.10 | -0.02 | -0.08 | -0.10 |
| Net P/L After Minority Interest & Share Of Associates | 482.92 | 301.41 | 403.21 | 610.35 | 46.87 |
| | | | | | |
| Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 17.11 | 10.68 | 14.29 | 21.63 | 1.66 |
| Diluted EPS (Rs.) | 17.11 | 10.68 | 14.28 | 21.62 | 1.66 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 17.11 | 10.68 | 14.29 | 21.63 | 1.66 |
| Diluted EPS (Rs.) | 17.11 | 10.68 | 14.28 | 21.62 | 1.66 |
| | | | | | |
| PBITOE Margin (%) | 15.71 | 16.30 | 18.33 | 36.68 | 13.80 |
| PBTE Margin (%) | 16.01 | 20.18 | 18.41 | 38.90 | 12.82 |
| PBT Margin (%) | 16.01 | 10.28 | 13.69 | 15.99 | 2.92 |
| PAT Margin (%) | 12.01 | 7.99 | 10.33 | 10.09 | 1.43 |
| PAT After MI And SOA Margin (%) | 12.01 | 7.99 | 10.33 | 10.09 | 1.43 |
